GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion.
葛兰素史克集团（纽约证券交易所代码：GSK）确认以15.8亿美元的价格出售Haleon plc（纽约证券交易所代码：HLN）的3.853亿股股份。
The shares represented around 4.2% of the issued share capital of Haleon.
这些股票约占Haleon已发行股本的4.2％。
Following the settlement of the placing, GSK will have fully exited its position and will no longer hold any ordinary shares in Haleon.
配售和解后，葛兰素史克将完全退出其头寸，将不再持有Haleon的任何普通股。
Following the demerger and premium listing of Haleon in July 2022, GSK initially retained a 12.94% stake in Haleon.
继2022年7月哈雷昂分拆并溢价上市后，葛兰素史克最初保留了哈雷昂12.94％的股份。
As a result of the disposals, GSK has sold 1.19 billion shares in Haleon for cumulative gross proceeds.
由于此次出售，葛兰素史克已出售了Haleon的11.9亿股股份，以获得累计总收益。
In October, GSK raised $1.1 billion, or £885.6 million, by selling some of its shares in Haleon, reducing its stake in the consumer healthcare business to around 7.4%.
10月，葛兰素史克通过出售其在Haleon的部分股份筹集了11亿美元，合8.856亿英镑，将其在消费者医疗保健业务中的股份减少至7.4％左右。
In May, GSK sold 240 million shares of Haleon in a move that has raised 804 million pounds for the firm. The offloaded shares are equivalent to up to 2.5% of Haleon's issued share capital.
5月，葛兰素史克出售了Haleon的2.4亿股股票，此举为该公司筹集了8.04亿英镑。卸下的股份相当于Haleon已发行股本的2.5％。
In March, Pfizer Inc (NYSE:PFE) announced plans to reduce its stake in Haleon to approximately 24%.
3月，辉瑞公司（纽约证券交易所代码：PFE）宣布计划将其在Haleon的股份减少至约24％。
Price Action: HLN shares are up 0.60% at $8.41 during the premarket session at last check Friday.
价格走势：在周五最后一次盘前交易中，HLN股价上涨0.60％，至8.41美元。
Now Read: Insider Activity Spotlight: Martin Harris Acquires In Colgate-Palmolive Stock Options
立即阅读：内幕活动聚焦：马丁·哈里斯收购高露洁-棕榄股票期权
Image: Wikimedia
图片：维基媒体